National PMDT Scale-up Plan - India - 2011-12 - TBC India
National PMDT Scale-up Plan - India - 2011-12 - TBC India
National PMDT Scale-up Plan - India - 2011-12 - TBC India
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>2011</strong><br />
1Q<br />
<strong>National</strong> <strong>Scale</strong> <strong>up</strong> <strong>Plan</strong> for Programmatic Management of DR TB <strong>2011</strong> - 20<strong>12</strong><br />
8.5. Enrollment plan of MDR suspects to be tested and patients to be initiated on<br />
treatment by Quarter and State<br />
It is planned to test 132,000 MDR TB suspects and initiate treatment for 24,000 MDR TB cases<br />
cumulatively over a period of 2 years (<strong>2011</strong>-20<strong>12</strong>), with an exponential increase over 8 quarters. The<br />
rapid rate of growth reflects rollout of services and switching of districts in phases by suspects criteria as<br />
well as diagnostic test, and has been consolidated from the state plans (Annexure 7, 9) into the national<br />
figures as depicted in the figure below.<br />
Figure 6: <strong>India</strong> <strong>India</strong>’s : Enrollment <strong>Plan</strong> <strong>Plan</strong> of MDR of MDR TB Suspects TB Suspects and Cases and in <strong>2011</strong> Cases and 20<strong>12</strong><br />
Number<br />
140000<br />
<strong>12</strong>0000<br />
100000<br />
80000<br />
60000<br />
40000<br />
20000<br />
0<br />
Sum of C-MDR Suspects Cum MDR Cases<br />
<strong>2011</strong><br />
2Q<br />
<strong>2011</strong><br />
3Q<br />
26<br />
<strong>2011</strong><br />
4Q<br />
20<strong>12</strong><br />
1Q<br />
20<strong>12</strong><br />
2Q<br />
20<strong>12</strong><br />
3Q<br />
20<strong>12</strong><br />
4Q<br />
Sum of C-MDR Suspects 3917 9144 19953 34525 54157 76152 100858 131516<br />
Cum MDR Cases 1078 2460 4657 7403 10895 14814 19138 24326<br />
8.6. <strong>Scale</strong> <strong>up</strong> plan in terms of geographical expansion and move towards universal access<br />
The scale-<strong>up</strong> of <strong>PMDT</strong> activities with timelines was planned for each state (Annexure -2) by geography<br />
and by criteria to prompt drug susceptibility testing, which is being scaled <strong>up</strong> nationwide in a phased<br />
manner. All States must communicate to CTD prior to switching MDR suspect criteria in any district to<br />
validate programme preparation, lab readiness, and drug-availability. The scale <strong>up</strong> by geography and<br />
suspects criteria is described in the table below:<br />
Table <strong>12</strong>: Summary of <strong>Scale</strong> <strong>up</strong> by Geography and Suspects Criteria<br />
Active 2010 <strong>2011</strong> 20<strong>12</strong><br />
States* (with at least 1 district implementing) <strong>12</strong> 35 35<br />
Total Districts implementing 141 390 605<br />
Under Criteria A 141 246 319<br />
Under Criteria B 0 141 251<br />
Under Criteria C 0 3 35
Change language